ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Acute Care

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,231Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 25

$477K Total Retail Price of All Prescriptions

Rank: 2 out of 25

649 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 649 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 5,111 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 290 239 1 6
LEVOTHYROXINE SODIUM 248 207 2 4
METFORMIN HCL 237 196 3 8
AMLODIPINE BESYLATE 219 206 4 2
HYDROCHLOROTHIAZIDE 192 163 5 11
PRAVASTATIN SODIUM 154 142 6 3
LISINOPRIL 151 144 7 5
DIOVAN HCT 115 97 8 61
OMEPRAZOLE 115 100 8 7
ATORVASTATIN CALCIUM 113 97 10 10
METOPROLOL TARTRATE 112 76 11 19
ALPRAZOLAM 110 97 12 44
POTASSIUM CHLORIDE 107 89 13 14
ALENDRONATE SODIUM 101 82 14 69
ZOLPIDEM TARTRATE 100 75 15 46
HYDROCODONE-ACETAMINOPHEN 87 66 S3 16 26
FLUTICASONE PROPIONATE 85 64 17 56
TRAMADOL HCL 84 61 18 18
ATENOLOL 84 84 18 31
NEXIUM 81 54 20 24
FENOFIBRATE 78 58 21 23
FUROSEMIDE 73 51 22 1
ADVAIR DISKUS 65 46 23 61
METOPROLOL SUCCINATE 63 54 24 9
DIOVAN 61 51 25 34
AZITHROMYCIN 60 39 26 25
MELOXICAM 60 54 26 27
CIPROFLOXACIN HCL 59 53 28 32
AMLODIPINE BESYLATE-BENAZEPRIL 56 48 29 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 45 30 97
TAMSULOSIN HCL 52 48 31 54
CLOPIDOGREL 51 51 32 28
GABAPENTIN 51 45 32 20
GLYBURIDE 50 39 R 34 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.